Photobiomodulation (PBM) and (dry) AMD | 59347
Journal of Clinical and Experimental Ophthalmology

Journal of Clinical and Experimental Ophthalmology
Open Access

ISSN: 2155-9570

Photobiomodulation (PBM) and (dry) AMD

Joint Meet on Annual Congress on Eye and Vision & International Conference on Euro Ophthalmology and Eye Surgery

May 13, 2021 | Webinar

Jerry Katzman


Scientific Tracks Abstracts: J Clin Exp Ophthalmol

Abstract :

A patient home undilated monitoring imaging system with physician alert for the monitoring by patients themselves. These patients are considered high risk for loss of sight and eventual blindness. Immediate intervention is needed in patients with diabetic retinopathy, AMD (wet and dry), optic neuritis, hemorrhage, stroke, vasculitis, optic neuritis and other pathologies. Once identified by their physician, continuous home monitoring becomes not only possible but sight saving.

Biography :

Jerry Katzman is the Company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Katzman has always been an entrepreneur, scientist, and pioneer in medical science. His focus has targeted various biotechnology companies, biopharma, and Wall Street. Upon completion of his medical training, Katzman joined a multi-specialty group practice in Brandon, FL where he founded and established the group’s department of ophthalmology. Katzman graduated from Boston University with a B.S. in Biomedical Engineering in 1974 and thereafter earned his M.D. from the Universidad de Guadalajara in Jalisco, Mexico

Top globaltechsummit